Concerns arise as Medisep 2 excludes essential eye treatment for age-related macular degeneration, risking vision for Kerala’s pensioners.

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So it works quite well as a VEGFR inhibitor and it is de-risked in that sense.

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of ...

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of Opht ...

Older age, lower visual acuity, and living alone are associated with anti-VEGF treatment discontinuation in patients with nAMD.

Amid controversy surrounding the eye treatment of Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan, the Pakistan Institute of Medical Sciences (PIMS) on Friday confirmed that he was taken to the ...

Pakistan Tehreek-e-Insaf founder and former premier Imran Khan received treatment for a retinal condition at Pakistan Institute of Medical Sciences (PIMS) Hospital over the weekend, the hospital's ...

To learn more about this topic, including the diagnosis and interdisciplinary management of MacTel, go to ...

W hen diagnosed with diabetic macular edema (DME) in 2017, Sarah Castaneda, 41, thought she would lose her eyesight completely. At least, that’s what her doctor told her would happen if she didn’t ...

Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly's ...

Under the merger terms, Eli Lilly will launch a tender offer to acquire all outstanding Adverum shares for up to $12.47 per share, consisting of $3.56 in cash at closing and a non-transferable ...